Asfuroğlu Mahmut, Selçuk Çobanoğlu Ahmet, Asfuroğlu Yonca, Fikret Cenk Zeki, Fikret Nil İrem Uçgun Zeki
Ankara Bilkent City Hospital, Department of Ophthalmology, Ankara, Türkiye.
University of Health Sciences, Ankara Bilkent City Hospital, Department of Ophthalmology, Ankara, Türkiye.
Photodiagnosis Photodyn Ther. 2025 Aug;54:104662. doi: 10.1016/j.pdpdt.2025.104662. Epub 2025 Jun 4.
This study aimed to examine alterations in the macular ganglion cell complex (GCC), peripapillary retinal nerve fiber layer (RNFL), and macular vasculature prior to the manifestation of evident outer retinal toxicity in patients receiving hydroxychloroquine (HCQ).
MATERIAL-METHOD: The present comparative cross-sectional study included 42 patients with no evident retinopathy who were taking <5 mg/kg HCQ for rheumatoid arthritis and 41 age-matched healthy subjects. Both groups were analyzed using swept-source optical coherence tomography (SS-OCT), comprising macular GCC and peripapillary RNFL. Macular vessel density (MVD) analysis was conducted using OCT angiography.
The superior (p = 0.04), inferior (p = 0.01), and total GCC (p = 0.02) values were significantly lower in the study group than in the control group. However, the RNFL and MVD measurements demonstrated no statistically significant disparities in any of the quadrants between the two groups (p > 0.05). The subgroup analysis revealed that patients who had received HCQ for ≥ 8 years demonstrated significantly lower superior, inferior, and total GCC thickness, in addition to thinner RNFL values in superior quadrants when compared to patients who had received HCQ for a period of < 8 years and the control group.
The present study demonstrated that after eight years of HCQ use at recommended doses, significant thinning of the inner retinal layers was observed in eyes exhibiting no evident retinal toxicity. It may be beneficial to include an inner retinal layer assessment in individuals chronically using HCQ as part of a comprehensive ophthalmic screening process.
本研究旨在检测接受羟氯喹(HCQ)治疗的患者在出现明显的视网膜外层毒性之前,黄斑神经节细胞复合体(GCC)、视乳头周围视网膜神经纤维层(RNFL)和黄斑血管系统的变化。
本比较性横断面研究纳入了42例无明显视网膜病变且类风湿关节炎服用<5mg/kg HCQ的患者以及41例年龄匹配的健康受试者。两组均使用扫频光学相干断层扫描(SS-OCT)进行分析,包括黄斑GCC和视乳头周围RNFL。使用OCT血管造影进行黄斑血管密度(MVD)分析。
研究组的上方(p = 0.04)、下方(p = 0.01)和总GCC值(p = 0.02)显著低于对照组。然而,RNFL和MVD测量显示两组在任何象限均无统计学显著差异(p>0.05)。亚组分析显示,与接受HCQ治疗<8年的患者和对照组相比,接受HCQ治疗≥8年的患者上方、下方和总GCC厚度显著降低,此外上方象限的RNFL值更薄。
本研究表明,在以推荐剂量使用HCQ八年后,在无明显视网膜毒性的眼中观察到视网膜内层显著变薄。将视网膜内层评估纳入长期使用HCQ个体的综合眼科筛查过程中可能有益。